Skip to main content
HeartCited

Niacin (Vitamin B3) per High Triglycerides (Hypertriglyceridemia)

B Evidenze Almeno un trial randomizzato lo supporta, con risultati per lo più coerenti.

Reduces triglycerides 20-50% dose-dependently. Particularly effective for combined dyslipidemia (high TG + low HDL). Flushing limits adherence with immediate-release forms.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dniacin\u0026condition\u003Dtriglycerides'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
In sintesi

            
            
Reduces triglycerides 20-50% dose-dependently. Particularly effective for combined dyslipidemia (high TG + low HDL). Flushing limits adherence with immediate-release forms.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                12 weeks
                
                
            

            
                Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A …
            
            

                
                Dose: 190 mg/d
                
                
                vs: None
                
                
                Outcome: Cholesterol levels
                
                
                Effetto: None
                
                
                p < 0.01
                
            

            
            
Popolazione: Aged individuals

            
        

        
        

            

                
                    In Vitro
                
                
                
                
            

            
                Immediate-release niacin and a monounsaturated fatty acid-rich meal on postprandial inflammation and monocyte characteristics in …
            
            

                
                Dose: 2 g
                
                
                vs: None
                
                
                Outcome: inflammation markers
                
                
                Effetto: None
                
                
                None
                
            

            
            
Popolazione: Healthy volunteers

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
8

        
Studi

    

    

        
4000

        
Partecipanti

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Grado

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study.
                        
                        
                            
                                RCT
                            
                            
                            
                        
                    

                    

                        Nutrients
                        2024
                        
                        5 citazioni
                        
                    

                

                
                

                    

                        
                            Immediate-release niacin and a monounsaturated fatty acid-rich meal on postprandial inflammation and monocyte characteristics in men with metabolic syndrome.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        Clinical nutrition (Edinburgh, …
                        2023
                        
                        11 citazioni
                        
                    

                

                
                

                    

                        
                            Hypertriglyceridemia.
                        
                        
                            
                                Other
                            
                            
                            
                        
                    

                    

                        The New England …
                        2008
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Dosaggi di uso comune

                

                    
                    

                        
generalnutrition:

                        
14-16 mg/day

                    

                    
                    

                        
lipidmodification:

                        
1,000-2,000 mg/day (start at 500 mg/day and titrate)

                    

                    
                

                
                

                    Limite massimo: 35 mg/day for non-prescription use; prescription doses up to 3,000 mg/day under medical supervi
                

                
            

            

            
            

                
Dosaggi studiati nella ricerca

                

                    

                        
                            

                                Dosaggio
                                Durata
                                Effetto
                                N
                            

                        
                        
                            
                            

                                190 mg/d
                                12 weeks
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                            

                                2 g
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                Momento migliore per l'assunzione: With dinner or at bedtime with a low-fat snack; aspirin 30 min before may reduce flushing
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Effetti collaterali segnalati

                    
    
                        
                        
  • 
                            ⚠
                            Flushing (redness, warmth, itching — most common, especially immediate-release)
                        
    • 
                        
                        
  • 
                            ⚠
                            Gastrointestinal discomfort (nausea, diarrhea)
                        
    • 
                        
                        
  • 
                            ⚠
                            Hepatotoxicity (especially extended-release at high doses)
                        
    • 
                        
                        
  • 
                            ⚠
                            Hyperglycemia (may worsen blood sugar control)
                        
    • 
                        
                        
  • 
                            ⚠
                            Hyperuricemia (may precipitate gout)
                        
    • 
                        
                    

                

                

                
                

                    
Interazioni note

                    
    
                        
                        
  • 
                            ●
                            Statins (increased risk of myopathy/rhabdomyolysis)
                        
    • 
                        
                        
  • 
                            ●
                            Blood pressure medications (additive hypotensive effect)
                        
    • 
                        
                        
  • 
                            ●
                            Diabetes medications (may counteract blood sugar control)
                        
    • 
                        
                        
  • 
                            ●
                            Anticoagulants (may increase bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            Alcohol (may worsen flushing and hepatotoxicity)
                        
    • 
                        
                    

                

                

                
                

                    

                        Livello di assunzione massimo tollerabile: 35 mg/day for non-prescription use; prescription doses up to 3,000 mg/day under medical supervi
                    

                

                
            

            

                Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Niacin (Vitamin B3) help with High Triglycerides (Hypertriglyceridemia)?
            
        
        

            Based on 8 studies with 4,000 participants, there is moderate evidence from clinical studies that Niacin (Vitamin B3) may support High Triglycerides (Hypertriglyceridemia) management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Niacin (Vitamin B3) should I take for High Triglycerides (Hypertriglyceridemia)?
            
        
        

            Studies have used various dosages. A commonly studied range is 14-16 mg/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Niacin (Vitamin B3)?
            
        
        

            Reported side effects may include Flushing (redness, warmth, itching — most common, especially immediate-release), Gastrointestinal discomfort (nausea, diarrhea), Hepatotoxicity (especially extended-release at high doses), Hyperglycemia (may worsen blood sugar control). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Niacin (Vitamin B3) and High Triglycerides (Hypertriglyceridemia)?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 8 peer-reviewed studies with 4,000 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                

                    
Altri ingredienti per High Triglycerides (Hypertriglyceridemia)

                    

                        
                        
                            Omega-3 Fatty Acids (EPA/DHA)
                            A

                        
                        
                        
                            Omega-7 (Palmitoleic Acid)
                            C

                        
                        
                        
                            Chitosan
                            D

                        
                        
                    

                

                

                
                

                    
Niacin (Vitamin B3) per altre condizioni

                    

                        
                        
                            High Cholesterol (Hyperlipidemia)
                            B

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Evgeny Pokushalov et al..
      Nutrients.
      2024.
      Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study.
      doi:10.3390/nu16132023
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Sergio Montserrat-de la Paz et al..
      Clin Nutr.
      2023.
      Immediate-release niacin and a monounsaturated fatty acid-rich meal on postprandial inflammation and monocyte characteristics in men with metabolic syndrome.
      doi:10.1016/j.clnu.2023.08.017
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Robert Oh.
      N Engl J Med.
      2008.
      Hypertriglyceridemia.
      doi:10.1056/NEJMc072844
      PubMed
    
    4. 
    
  















    

        Avvertenza FDA:
        Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.